Lucid Peptides is a UK-based vendor operating under a hybrid retail and bulk sales model. The company maintains a catalogue of 48 peptides and requires a minimum order of one vial per transaction. Currently, there is no publicly available evidence of third-party testing or COA documentation for their inventory. Because the vendor lacks a significant footprint of community feedback or verified testing data, the available information regarding their operational reliability remains limited.
Data last updated
Anecdotal signals
Price
regional price-per-mg comparisons · prices checked 8d ago
We don't issue verdicts — we publish the evidence and let it speak. Our automated site audit has verified the vendor's published catalogue and COA surface. So far we have captured no substantiated community reports and no lab documents for Lucid Peptides. That absence is itself information: it does not prove anything is wrong, but it means independent evidence is thin — proceed accordingly.
A vendor COA library is observable on the site but no individual COAs were captured in this pass.